ALS Communication BCIs are specialized brain-computer interfaces designed to restore communication abilities for patients with Amyotrophic Lateral Sclerosis (ALS), particularly those in the locked-in state who have lost all voluntary motor control. These systems represent one of the most clinically advanced applications of BCI technology.
As ALS progresses, patients lose:
- Limb movement control
- Speech and swallowing ability
- Eventually, eye movement (complete locked-in state)
This leaves patients fully conscious but unable to communicate, creating severe quality of life impacts.
- ~30,000 Americans with ALS
- ~50% require communication assistance within 3 years of diagnosis
- ~20% develop complete locked-in syndrome
- Communication BCIs offer the only independent communication method
The most clinically validated invasive approach:
- Electrode: 100-channel Utah Array in motor cortex
- Signal: Single-unit neural activity
- Performance: Up to 6-8 bits/minute typing speed
- Clinical trial: BrainGate2 (NCT00912041)
- Users: Paralysis patients achieving text entry, robotic control
First-generation implantable BCI:
- Electrodes: 1024 channels across 64 threads
- Signal: Individual neuron activity
- Trial: PRIME Study in ALS/quadriplegia patients
- Advantage: Wireless, high bandwidth
- P300 Speller: Uses oddball paradigm to detect intended characters
- SSVEP: Steady-state visually evoked potentials
- Motor Imagery: Imagined movement to select options
- Speed: 2-5 bits/minute (slower but no surgery)
- Method: Near-infrared spectroscopy for hemodynamic response
- Advantage: Portable, resistant to motion artifacts
- Use: Basic yes/no communication
| Year |
Study |
Participants |
Key Results |
| 2006 |
Hochberg et al. |
1 |
First cursor control |
| 2012 |
Hochberg et al. |
3 |
Robotic arm control |
| 2021 |
Willett et al. |
2 |
90 characters/min with neural decoding |
| 2023 |
Million et al. |
5 |
99% accuracy in letter selection |
- NCT: NCT04288683
- Status: Ongoing (as of 2024-2025)
- Results: First patient achieved cursor control within weeks
- Speed: Approaching able-bodied typing speeds
- P300 Speller: FDA cleared for clinical use
- Accuracy: 90-99% with calibration
- Setup time: 15-30 minutes
¶ Key Companies and Programs
-
Neuralink (N1, Link)
- First wireless, high-channel-count implant
- PRIME Study for ALS/quadriplegia
-
Blackrock Neurotech (Utah Array variants)
- Longest clinical history
- BrainGate consortium partner
-
Paradromics (CONNERGE)
- High-bandwidth 65,000 electrode array
- Focused on ALS communication
-
g.tec Medical Engineering
- BCI P300 Speller (FDA cleared)
- g.NAmp research systems
-
EMOTIV
- EPOC portable EEG headset
- Consumer/research BCI
-
OpenBCI
- Open-source EEG platforms
- Research community standard
- Independence: Patients communicate without caregiver assistance
- Autonomy: Make choices about care, environment
- Emotional connection: Maintain relationships with family
- End-of-life: Express wishes, participate in decisions
- Reduced anxiety and depression
- Improved sense of purpose
- Maintained identity and agency
¶ Challenges and Limitations
- Speed: Even best systems slower than speech (~150 wpm)
- Training: Requires significant calibration time
- Maintenance: Invasive systems need maintenance
- Cost: High device and surgery costs
- Cost: $50,000-150,000 for invasive systems
- Availability: Limited clinical trial sites
- Insurance: Often not covered
- Caregiver support: Still needed for setup
- Increase typing speed to 60+ wpm
- Reduce calibration time to <10 minutes
- Improve accuracy in complete locked-in state
- Develop fully implantable systems